ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Revolution Medicines
The Director, US Medical Affairs, PDAC supports the development and execution of the US Medical Affairs strategy and tactical plan for pancreatic ductal adenocarcinoma (PDAC). This role serves as a medical and scientific partner for cross-functional teams, translating the evolving PDAC treatment landscape and field insights into focused medical priorities and activities. The position contributes to launch readiness, post-approval medical activities, and evidence generation while ensuring compliance with legal and regulatory requirements.
Headquarters
Redwood City, California, United States
Company Size
201-500 employees
Founded
2014
Revolution Medicines (RevMed) is a biopharmaceutical company dedicated to discovering, developing, and delivering novel targeted medicines for patients with cancer. Their mission focuses specifically on "revolutionizing treatment for patients with RAS‑addicted cancers" through precision-targeted therapies. The company emphasizes a science-driven, end-to-end approach from discovery to delivery. RevMed brands its team as "Revolutionaries" committed to transforming outcomes for people with RAS‑driven tumors.
MarketBeatVictory Capital Management Inc. Trims Stock Holdings in Revolution Medicines, Inc. $RVMD
13 hours ago
Simply Wall StRevolution Medicines Trials, Funding Capacity And Insider Moves Shape Risk Outlook
5 days ago
GlobeNewswireRevolution Medicines Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Revolution Medicines.
Yahoo FinanceRevolution Medicines, Inc. (RVMD) Net Loss Widens amid Progress on Clinical Trial Programs
1 week ago
Senior Vice President (SVP), Global & US Medical Affairs
Tango Therapeutics
Intern, Translational Data Science (Project: Characterizing Immune States in PDAC and Their Impact on Disease Progression)
Genmab
Sr. Medical Scientist - US Medical Affairs, Obesity and Related Conditions
Amgen
Medical Director, US Medical Affairs
Dyne Therapeutics
Head of Solid Tumors US Medical Affairs Oncology
BioLife Plasma Services
US Director of Medical Affairs (US DMA), Pulmonary Hypertension
MSD
